Word

KELVRI

Status

Pending

Status Code

688

Status Date

Tuesday, January 2, 2024

Serial Number

88728518

Mark Type

4000

Filing Date

Monday, December 16, 2019

Published for Opposition

Tuesday, November 7, 2023

Trademark Owner History

Teva Pharmaceuticals USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

Trademark Events

Jan 2, 2024

Noa E-Mailed - Sou Required From Applicant

Nov 7, 2023

Official Gazette Publication Confirmation E-Mailed

Nov 7, 2023

Published For Opposition

Oct 18, 2023

Notification Of Notice Of Publication E-Mailed

Oct 5, 2023

Approved For Pub - Principal Register

Apr 2, 2023

Report Completed Suspension Check Case Still Suspended

Oct 2, 2022

Report Completed Suspension Check Case Still Suspended

Mar 23, 2022

Report Completed Suspension Check Case Still Suspended

Sep 23, 2021

Report Completed Suspension Check Case Still Suspended

Mar 21, 2021

Report Completed Suspension Check Case Still Suspended

Sep 21, 2020

Report Completed Suspension Check Case Still Suspended

Mar 16, 2020

Notification Of Letter Of Suspension E-Mailed

Mar 16, 2020

Letter Of Suspension E-Mailed

Mar 16, 2020

Suspension Letter Written

Mar 16, 2020

Assigned To Examiner

Dec 19, 2019

New Application Office Supplied Data Entered

Dec 19, 2019

New Application Entered